News Headlines Article

Mixed Result for Bone Drug in Cancer Study
New York Times

The results of a new study are tempering hopes that a drug used to treat bone loss might also help stave off relapses of breast cancer, especially for younger women, researchers said Thursday.

The clinical trial found that women with early breast cancer who were treated with the bone drug zoledronic acid did not have fewer recurrences of their cancer than women who did not receive the drug.